Elsevier BV provides LaTeX templates for many of its journals. Check this journal’s author guidelines, and we can convert your manuscript into its template.
LaTeX Template Conversion →01Impact factor
Impact factor of Transfusion Clinique et Biologique (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Transfusion Clinique et Biologique published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Hematologyrank 94 of 104 journals
- Immunologyrank 178 of 189 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Transfusion Clinique et Biologique
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Transfusion Clinique et Biologique is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Article processing charge listed at about US$1,820.
Is your paper a fit for Transfusion Clinique et Biologique?
Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.
Check my paper for this journalOr find journals that fit my paper
Need a faster review? The fastest journals in Immunology accept papers in a median of 14 days.
- HLA 14 days
- Immunological Reviews 33 days
- Clinical and Experimental Vaccine Research 40 days
APC waivers and discounts for Transfusion Clinique et Biologique APC about US$1,820
Elsevier: automatic 100% waiver for Research4Life Group A and 50% for Group B in fully open access journals, but only when every author is in an eligible country. Authors in 82 countries get a full waiver.
02Retractions
Retractions and research integrity at Transfusion Clinique et Biologique
Transfusion Clinique et Biologique has 1 retracted paper on record, the latest in Jun 2020. A retraction count is not a verdict on a journal: large journals publish more and journals that investigate actively retract more. The trend and the reasons tell you more than the number.
03Funders
Who funds research published in Transfusion Clinique et Biologique
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
04Indexing
Indexing of Transfusion Clinique et Biologique
- ISSN
- 1246-7820
- eISSN
- 1953-8022
- Publisher
- Elsevier BV all its journals →
- Subjects
- Hematology, Immunology
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
05How to submit
How to submit to Transfusion Clinique et Biologique
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Transfusion Clinique et Biologique accepts. Open the official guide for authors and submit from the same page.
- Use the journal's template. Elsevier BV offers Word and LaTeX templates for many of its journals. If your manuscript is in Word and the journal wants LaTeX, our LaTeX Template Conversion moves it into the template. If the language or structure needs work first, manuscript editing by a PhD editor in your field is priced by word count (see the editing cost guide).
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. Transfusion Clinique et Biologique is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
06Reviewer comments
Reviewer comments and rejection reasons for Transfusion Clinique et Biologique
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Transfusion Clinique et Biologique, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Worried about the English? Manuscript editing by editors in your subject: see the price →
Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds07Same subject
Hematology journals with a similar impact factor*
The journals next to Transfusion Clinique et Biologique when the 103 journals of Hematology in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 90 | Iraqi Journal of Hematology | 0.45 | ESCI | Fully open access |
| 91 | GEMATOLOGIYA I TRANSFUZIOLOGIYA | 0.45 | SCIE | Some open access |
| 92 | Case Reports in Hematology | 0.43 | ESCI | Fully open access |
| 93 | Indian Journal of Hematology and Blood Transfusion | 0.41 | SCIE | Subscription |
| 95 | The American Journal of Hematology | 0.33 | SCIE | Subscription |
| 96 | Asian Journal of Transfusion Science | 0.27 | ESCI | Fully open access |
| 97 | Clinical Lymphoma Myeloma & Leukemia | 0.25 | SCIE | Subscription |
| 98 | The Egyptian Journal of Haematology | 0.22 | ESCI | Subscription |
*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.
Is Transfusion Clinique et Biologique right for your paper? Find the right journal
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 157,375 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.
08Questions
Frequently asked questions
What is the impact factor of Transfusion Clinique et Biologique?
Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Transfusion Clinique et Biologique is 0.39: papers it published in the two previous years were cited 0.39 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Transfusion Clinique et Biologique?
The h-index of Transfusion Clinique et Biologique is 53 (October 2026): 53 of its papers have each been cited at least 53 times. Its i10-index is 503.
What is the APC of Transfusion Clinique et Biologique?
The listed article processing charge (APC) is about US$1,820 for Transfusion Clinique et Biologique (data from October 2026). APCs change and can differ by article type, country or discounts, so confirm the current charge on the journal’s website before submitting.
What is the quartile of Transfusion Clinique et Biologique?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Transfusion Clinique et Biologique is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Transfusion Clinique et Biologique indexed in Scopus?
Yes. Transfusion Clinique et Biologique appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Transfusion Clinique et Biologique an SCIE journal?
Yes. Transfusion Clinique et Biologique is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Transfusion Clinique et Biologique in Journal Citation Reports (JCR)?
Yes. Transfusion Clinique et Biologique is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Does Transfusion Clinique et Biologique offer an APC waiver?
Transfusion Clinique et Biologique follows the policy of Elsevier: automatic 100% waiver for Research4Life Group A and 50% for Group B in fully open access journals, but only when every author is in an eligible country. Rules verified 27 October 2026; confirm on the publisher's page.
Has Transfusion Clinique et Biologique retracted papers?
Yes. 1 retracted paper are on record for Transfusion Clinique et Biologique, 1 of them in the last 10 years. A retraction count alone is not a verdict on a journal; look at the trend and the reasons. Data updated October 2026.
Who funds research published in Transfusion Clinique et Biologique?
6% of 200 recent research articles in Transfusion Clinique et Biologique name a funder; the funders named most often are All-India Institute of Medical Sciences, Etablissement Français du Sang, Swami Rama Himalayan University.
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Applied Sciences
- Solid State Communications
- Sensors
- Journal of Physical Chemistry B
- Fuel
- Analytica Chimica Acta
- Journal of Applied Physics
- ACS Applied Materials and Interfaces
- Thin Solid Films
- Ceramics International
- American Journal of Cardiology
- Journal of Applied Polymer Science
- Physics Letters A
- Journal of Chemical Physics
Browse all journals: indexing, impact factor and reviewer comments →